Andrea Elena Iglesias Molli

Andrea Elena Iglesias Molli

Auto-generated profile, based on publicly available information

Andrea Elena Iglesias Molli

Laboratorio de Genética y Metabolismo CONICET‐Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo (INIGEM) Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAndrea Elena Iglesias Molli
Andrea Elena Iglesias Molli
ASAlberto Penas Steinhardt
Alberto Penas Steinhardt
ALAriel Pablo López
Ariel Pablo López
CGClaudio Daniel Gonzalez
Claudio Daniel Gonzalez
JVJorge Vilariño
Jorge Vilariño
GCGloria Edith Cerrone
Gloria Edith Cerrone
The Metabolic Syndrome (MetS) is a cluster of cardiometabolic risk factors, usually accompanied by the presence of insulin resistance (IR) and a systemic subclinical inflammation state. Metabolically healthy obese (MHO) individuals seem to be protected against cardiometabolic complications. The aim of this work was to characterize phenotypically the low-grade inflammation and the IR in MHO individuals in comparison to obese individuals with MetS and control non obese. We studied two different populations: 940 individuals from the general population of Buenos Aires and 518 individuals from the general population of Venado Tuerto; grouped in three groups: metabolically healthy non-obese individuals (MHNO), MHO and obese individuals with MetS (MSO). Inflammation was measured by the levels of hs-CRP (high-sensitivity C reactive protein), and we found that MHO presented an increase in inflammation when compared with MHNO (Buenos Aires: p<0.001; Venado Tuerto: p<0.001), but they did not differ from MSO. To evaluate IR we analyzed the HOMA (Homoeostatic Model Assessment) values, and we found differences between MHO and MSO (Buenos Aires: p<0.001; Venado Tuerto: p<0.001), but not between MHNO and MHO. In conclusion, MHO group would be defined as a subgroup of obese individuals with an intermediate phenotype between MHNO and MSO individuals considering HOMA, hs-CRP and central obesity.

14 May 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
MVMariela Edith Velazquez
Mariela Edith Velazquez
AMAndrea L. Millan
Andrea L. Millan
MRMailén Rojo
Mailén Rojo
GAGiselle Adriana Abruzzese
Giselle Adriana Abruzzese
SCSilvina Ema Cocucci
Silvina Ema Cocucci
GCGloria Edith Cerrone
Gloria Edith Cerrone
Background: Polycystic Ovary Syndrome (PCOS) often present metabolic disorders and hyperandrogenism (HA), facts that may influence the telomere length (TL). Aims: To compare the absolute TL (aTL) between women with PCOS and control women, and their association with the presence of obesity and HA parameters. Materials and methods: The PCOS group included 170 unrelated women outpatients and the control group, 64 unrelated donor women. Anthropometric, biochemical-clinical parameters and androgen profile were determined. The PCOS patients were divided accordingly to the presence of obesity and androgenic condition. The aTL was determined from peripheral blood leukocytes by Real Time quantitative PCR. Results: Women with PCOS exhibited a significantly longer aTL than controls after age adjustment (p=0.001). A stepwise multivariate linear regression in PCOS women, showed that WC (waist circumference) contributed negatively (b=-0.17) while testosterone levels contributed positively (b=7.24) to aTL. The non-Obese PCOS (noOB-PCOS) presented the longest aTL when compared to controls (p=0.001). Meanwhile, the aTL was significantly higher in the hyperandrogenic PCOS phenotype (HA-PCOS) than in the controls (p=0.001) and non hyperandrogenic PCOS phenotype (NHA-PCOS) (p=0.04). Interestingly, when considering obesity and HA parameters in PCOS, HA exerts the major effect over the aTL as non-obese HA exhibited the lengthiest aTL (23.9 ± 13.13 Kbp). Conversely, the obese NHA patients showed the shortest aTL (16.5 ± 10.59 Kbp). Conclusions: Whilst a shorter aTL could be related to the presence of obesity, a longer aTL would be associated with HA phenotype. These findings suggest a balance between the effect produced by the different metabolic and hormonal components, in PCOS women.

1 January 2016 in Revista Argentina de Endocrinologia Y Metabolismo
Verified
Journal Article
Open access
AMAndrea Elena Iglesias Molli
Andrea Elena Iglesias Molli
AMAndrea Millán
Andrea Millán
JVJorge Vilariño
Jorge Vilariño
CGClaudio Daniel Gonzalez
Claudio Daniel Gonzalez
MSMarta Sereday
Marta Sereday
GFGustavo Daniel Frechtel
Gustavo Daniel Frechtel
ResumenLa obesidad es el principal componente del síndrome metabólico (SM) y determina la progresión de la enfermedad a las complicaciones metabólicas. Los individuos obesos metabólicamente sanos (OMS) parecen estar protegidos contra esas complicaciones. La longitud de los telómeros (LT) es un nuevo marcador del envejecimiento celular, que tiene una relación compleja con el SM. El objetivo principal de este estudio fue investigar por primera vez la LT en OMS y estudiar la asociación entre LT y el número de componentes del SM.Se estudió a 398 mujeres con una edad media de 46,76±15,47 años (rango: 18-86 años), que se agruparon en: individuos con normopeso sin ningún componente del SM (NP0), obesos sin SM (OMS) y de acuerdo con el número de componentes de SM en los grupos sin ningún componentes de SM (0), con uno o 2 componentes (1+2) y con SM por la presencia de 3 o más componentes (SM).La LT de los OMS no se diferenció de la de los NP0, pero fue significativamente mayor que la de los individuos con SM (p=0,032). Se observó una disminución de la LT con el aumento progresivo del número de componentes del SM (p=0,004), en donde el grupo 0 presentó una LT significativamente mayor que los grupos 1+2 (p=0,027) y SM (p=0,003).Demostramos por primera vez que las mujeres OMS presentan una LT similar a las mujeres NP0 y más larga que aquellas mujeres con SM. Además, confirmamos que la LT se acorta con el aumento en el número de alteraciones del SM.AbstractObesity is the principal component in Metabolic Syndrome (MetS) and determines the progression of metabolic complications. Metabolically healthy obese individuals (MHO) seem to be protected against those complications. Telomere length (TL), as a novel marker of cellular aging, has a complex relationship with MetS. The principal aim of this study was to investigate TL in MHO, and to study the association between TL and the number of MetS components.A study was conducted on 398 women (mean age: 46.76±15.47 years; range: 18 - 86 years), grouped according to the number of MetS components (0, 1+2, MetS), a group of normal-weight individuals with 0 MetS components (NW0), and a group of obese without MetS (MHO).No differences were found in the TL of the MHO group compared to the NW0, but it was significantly higher than that of individuals with MetS (P=.032). A decrease in TL was observed with a progressive increase in the number of MetS components (P=.004), whereas the group of individuals without MetS components had significantly longer TL than the groups with 1 and 2 components (P=.027), and MetS (P=.003).Shorter TL is not associated with MHO, but is related to MetS and with an increased number of metabolic abnormalities

27 September 2026 in Pediatric Obesity
Verified
Journal Article
Closed access
MRMailén Rojo
Mailén Rojo
AMAndrea Liliana Millán
Andrea Liliana Millán
ADAlejandra Beatriz Duarte
Alejandra Beatriz Duarte
AMAndrea Elena Iglesias Molli
Andrea Elena Iglesias Molli
GFGustavo Daniel Frechtel
Gustavo Daniel Frechtel
HPHernán Pérez
Hernán Pérez